Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
04 Décembre 2024 - 2:30PM
Business Wire
On Monday, Encompass Health and Enhabit won their lawsuit in the
Delaware Court of Chancery related to breaches of fiduciary duty by
April Anthony, Luke James, and Chris Walker while they served as
the senior officers at Encompass Health’s former home health and
hospice division, which is now Enhabit. The Court awarded judgment
against private equity firms Vistria Group and Nautic Partners and
the home health and hospice business now known as VitalCaring Group
for aiding and abetting “the egregious breaches of the duty of
loyalty” by Anthony, James, and Walker.
The case was the subject of a 7-day trial in December 2023.
After considering “the damning record presented at trial,” the
Court found that, while employed by Encompass Health, Anthony,
James, and Walker usurped acquisition opportunities falling within
Encompass Health’s line of business, used Encompass Health’s
confidential information, and swayed key Encompass Health employees
to join them with the promise of equity in the home health and
hospice competitor that Anthony now heads. The Court noted that
Anthony, James, Walker, and the private equity defendants took
“great pains” to hide their misconduct, going so far as to secretly
exchange diligence materials about acquisition targets for the new
venture. The Court determined that VitalCaring Group, Anthony’s new
company, is “the result of this deceit.”
In addition to finding breaches of fiduciary duty by Anthony and
the other two former Encompass Health officers, the Court also
found that “with full awareness that their actions were wrong,”
Vistria and Nautic and two of their principals, David Schuppan and
Christopher Corey, “drove the fiduciaries’ efforts to covertly
siphon opportunities, information, resources, and employees from
Encompass.”
As a remedy for these actions, the Court of Chancery imposed a
constructive trust entitling Encompass Health and Enhabit to
receive 43 percent of VitalCaring Group’s profits, to be paid
quarterly, and 43 percent of the exit proceeds if and when
VitalCaring Group is sold. The Court also awarded mitigation
damages in the amount of approximately $1.62 million, and awarded
attorneys’ fees based on the defendants’ bad faith efforts to
conceal their misdeeds, which included falsifying records, deleting
evidence, and “manipulating communications through lawyers.”
Encompass Health and Enhabit launched the litigation to protect
the interests of their stockholders in the wake of the illegal and
outrageous conduct of Anthony and the other former officers.
Encompass Health and Enhabit believe the broader investing public
will also benefit from the Delaware Court of Chancery’s clear
message that intentional breaches of fiduciary duty and
self-dealing by corporate officers will have severe consequences.
Those self-dealing officers and their co-conspirators will not be
permitted to benefit themselves at the expense of a corporation’s
stockholders.
The defendants in the case who were found liable include Walker,
The Vistria Group, Vistria Fund III, Vistria senior partner David
Schuppan, Nautic Partners, Nautic Partners IX, Nautic managing
director Christopher Corey, and the holding company that owns
VitalCaring Group.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator
of rehabilitation hospitals in the United States. With a national
footprint that includes 166 hospitals in 38 states and Puerto Rico,
the Company provides high-quality, compassionate rehabilitative
care for patients recovering from a major injury or illness, using
advanced technology and innovative treatments to maximize recovery.
Encompass Health is ranked as one of Fortune's World’s Most Admired
Companies and Becker’s Hospital Review’s 150 Top Places to Work in
Healthcare. For more information, visit encompasshealth.com, or
follow us on our newsroom, Twitter, Instagram and Facebook.
About Enhabit Home Health & Hospice
Enhabit Home Health & Hospice (NYSE: EHAB) is a leading
national home health and hospice provider working to expand what’s
possible for patient care in the home. Enhabit's team of clinicians
supports patients and their families where they are most
comfortable, with a nationwide footprint spanning 256 home health
locations and 112 hospice locations across 34 states. Enhabit
leverages advanced technology and compassionate teams to deliver
extraordinary patient care. For more information, visit
ehab.com.
Forward-Looking Statements
Statements contained in this press release which are not
historical facts, such as those relating to the likelihood, timing
and allocation of any monetary remedies recovered by Encompass
Health and Enhabit, are forward-looking statements. In addition,
Encompass Health or Enhabit may from time to time make
forward-looking public statements concerning the matters described
herein. All such estimates, projections, and forward-looking
information speak only as of the date made, and neither Encompass
nor Enhabit undertakes a duty to publicly update or revise such
forward-looking information, whether as a result of new
information, future events, or otherwise. Such forward-looking
statements are necessarily estimates based upon current information
and involve a number of risks and uncertainties. Actual results or
events may differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors.
While it is impossible to identify all such factors, factors which
could cause actual results or events to differ materially from
those anticipated include, but are not limited to, an appeal of the
verdict by the defendants and any related adverse appellate
decision; the financial position of the defendants to the extent it
may limit the timeliness or ability of the defendants to deliver
any monetary remedy awarded, including future profits and exit
proceeds, if any, to be delivered through the constructive trust
ordered by the court; and other factors which may be identified
from time to time in Encompass Health’s or Enhabit’s SEC filings
and other public announcements, including in the Forms 10-K for the
year ended Dec. 31, 2023 and Forms 10-Q for the quarters ended Mar.
31, 2024, Jun. 30, 2024, and Sept. 30, 2024 for either Encompass
Health or Enhabit.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241203092718/en/
Encompass Health contacts:
Media: Polly Manuel | 205 970-5912
polly.manuel@encompasshealth.com
Investor Relations: Mark Miller | 205 970-5860
mark.miller@encompasshealth.com
Enhabit contacts: Media: Erin Volbeda | 972 338-5141
media@ehab.com
Investor Relations: Jobie Williams | 469 860-6061
investorrelations@ehab.com
Enhabit (NYSE:EHAB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Enhabit (NYSE:EHAB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024